A Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia

Sponsor
Istituto Clinico Humanitas (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05804266
Collaborator
(none)
40
1
2
13
3.1

Study Details

Study Description

Brief Summary

Achalasia is an idiopathic esophageal motility disorder, characterized by the insufficient relaxation of the lower esophageal sphincter (LES) and the absence of peristalsis in the esophageal body, leading to disabling symptoms, such as dysphagia, regurgitation, chest pain and weight loss. Until a few years ago, common interventional therapeutic approaches included botulinum toxin injection, endoscopic pneumatic balloon dilation and laparoscopic Heller myotomy. Nevertheless, the first options have proved only limited efficacy, while the surgical approach is highly invasive, costly and burdened by potential severe complications and a long recovery.

First described by Inoue et al., peroral endoscopic myotomy (POEM) has recently been introduced as a novel treatment option. This innovative technique consists in creating a submucosal tunnel and cutting the esophageal muscular fibers with a less invasive approach than surgery. Due to the excellent clinical success rates achieved in both the short- and long-term with few adverse events, POEM has rapidly became one of the most common therapeutic approaches for esophageal achalasia. However, despite these great results, it is still an expensive, length, difficult and risky procedure.

Indeed, the creation of submucosal tunnel is hampered by frequent intra-procedural bleeding that makes the procedure troublesome and time-consuming, requiring often the need of costly hemostatic devices such as the coagulation forceps. Such risk may also become clinically relevant as it may lead to major delayed bleeding that in turn may require hospitalization, blood transfusions and retreatment of the patient.

No clear strategy to reduce the risk of intra-procedural and delayed bleeding has been put forward. Current practice consists of the preventive isolation and coagulation of the designed vessels during the submucosal tunneling.

What the investigator propose in this protocol is a new technique to prevent the risk of bleeding and make POEM easier, quicker, safer and cheaper. Indeed, the invetsigators noticed that preventive underwater coagulation of the candidate vessels during the submucosal tunneling with the Hybrid Knife (HK), may seal the wall of the vessel, resulting in a subsequent cut under CO2 without any bleeding. Such preventive coagulation is likely to be related with the conduction of the current underwater as it focalizes all the power on the interface between the vessel and the water, allowing a soft sealing of the vessel without cutting it.

The hypothesis of the investigators is that the implementation of this novel approach in clinical practice may lead to an increase in safety, feasibility and cost-effectiveness, reducing the procedural time, the rate of complications and the need for coagulation forceps in comparison with the conventional preventive coagulation technique under CO2 insufflation.

Therefore, this randomized study compares the novel underwater precoagulation technique with the conventional precoagulation technique in the CO2 setting during the submucosal tunneling.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Coventional coagulation
  • Procedure: Underwater coagulation
  • Procedure: Peroral endoscopic myotomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: POEM with conventional precoagulation

Procedure: Coventional coagulation
Coventional coagulation

Procedure: Peroral endoscopic myotomy
Peroral endoscopic myotomy

Experimental: POEM with underwater precoagulation

Procedure: Underwater coagulation
Underwater coagulation

Procedure: Peroral endoscopic myotomy
Peroral endoscopic myotomy

Outcome Measures

Primary Outcome Measures

  1. Bleeding [12 months]

    Rate of bleeding requiring the use of coagulation forceps

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All >18 years-old patients undergoing POEM for esophageal achalasia
Exclusion Criteria:
  • patients on antithrombotic/anticoagulant therapy

  • patients suffering from bleeding disorders

  • patients with esophageal and/or gastric varices

  • patients previously treated with POEM or Heller myotomy

  • patients who were not able or refused to give informed written consent.

  • vessels equal or more than the knife inner diameter (120 μm)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Humanitas Research Hospital Milano Italy 20089

Sponsors and Collaborators

  • Istituto Clinico Humanitas

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Istituto Clinico Humanitas
ClinicalTrials.gov Identifier:
NCT05804266
Other Study ID Numbers:
  • 222
First Posted:
Apr 7, 2023
Last Update Posted:
Apr 7, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2023